Results 231 to 240 of about 89,572 (287)

Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity. [PDF]

Br J Cancer
Turnham DJ, French R, Frame FM, Meniel VS, Maitland NJ, Clarkson RWE.   +5 more
europepmc   +1 more source

Stimuli‐Responsive Poly(Disulfide)s: A Versatile Platform for Intelligent Drug Delivery Systems

MedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
Ring‐opening polymerization based on dynamic disulfide bond exchange is an important method for synthesizing poly(disulfide)s. These polymers possess stimulus‐responsive mechanisms and show broad prospects in intelligent drug delivery. This review systematically discusses the ring‐opening polymerization strategy and research progress of drug delivery ...
Yuechen He, Qiuhong Ouyang, Xinglv Chen, Qian Zhong, Xunhuan Song, Yujie Sun, Bingran Yu, Meng Qin   +7 more
wiley   +1 more source

Real-world Treatment Selection and Shared Decision-making in De Novo Metastatic Castration-sensitive Prostate Cancer in Japan. [PDF]

Cancer Diagn Progn
Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T.   +5 more
europepmc   +1 more source

The Use of FN‐Silk Networks as Extracellular Matrix‐Mimicking Support for 3D In Vitro Breast Cancer Models Improved the Model's Reproducibility in Drug Sensitivity

MedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
Chemotherapy treatment experiments were conducted on three breast cancer cell lines cultured in 2D, spheroids, and the novel 3D support: FN‐silk networks. The breast cancer cells cultured in FN‐silk networks were generally less sensitive to the drugs tested, compared to 2D cultures, potentially giving higher clinical relevance.
Suha Karrani, Astrid Källén, Caterina Collodet, Serge Ducommun, Mona Widhe, My Hedhammar   +5 more
wiley   +1 more source

Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer (ARETTA). [PDF]

JCO Glob Oncol
Ntekim A, Popoola A, Sowunmi A, Olasehinde O, Sanni A, Ibraheem A, Zheng Y, Yoshimatsu TF, Dosunmu GT, Omoleye O, Folasire A, Adeniji-Sofoluwe A, Omisore A, Adewumi A, Olajide T, Lawal R, Komolafe A, Omodele F, Ajani M, Michael O, Balogun B, Ale OK, Irurhe N, Folorunso S, Oyekan A, Kotila O, Aniagwu T, Odetunde A, Ilona S, Ajani AO, Oshin A, Onitilo A, Asuzu C, Daramola A, Abdulkareem F, Balogun OO, Karrison T, Babalola P, Huo D, Olopade CO, Obafunwa J, Ojengbede O, Olopade OI.   +42 more
europepmc   +1 more source

Retraction: Real-World Outcomes of Peri-Operative Chemotherapy With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel in Upper Gastrointestinal Cancers: An Audit of Patients Diagnosed Between 2017 and 2020 at the Christie Hospital. [PDF]

Cureus
Sabry M, Mahmoud Y, Hatahet Y, Patel R, Ibrahim N.   +4 more
europepmc   +1 more source

A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer. [PDF]

Clin Cancer Res
Medina S, Tokuyama N, Hammouda K, Pathak T, Mirtti T, Fu P, Gupta S, Lal P, Sandler HM, Correa R, Chafe S, Shah A, Efstathiou JA, Hoffman K, Straza M, Hallman MA, Jordan R, Pugh SL, Sweeney CJ, Madabhushi A.   +19 more
europepmc   +1 more source

Antibody–drug conjugate combined with chemoimmunotherapy: Redefining the neoadjuvant strategy for human epidermal growth factor receptor 2‐overexpressing locally advanced gastric cancer

Clinical and Translational Discovery, Volume 6, Issue 3, June 2026.
Shulun Nie, Cunliang Wang, Xiaolan Cao, Shuyi Song, Yu Wang   +4 more
wiley   +1 more source

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial.

BMJ
Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Zhou S, Li P, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Yao G, Fan Y, Lin J, Zhu X, Xu B.   +29 more
europepmc   +1 more source

Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors. [PDF]

Front Oncol
Italiano A, García Manrique T, Grande Pulido E, Kerrigan K, Fléchon A, Martínez Pérez J, Żurawski B, Furqan M, Juan-Vidal O, Vaishampayan U, Fares C, Fang B, Vicuna B, Greillier L, Subbiah V, Dong M, Song K, Zhang Y, Kim Y, Paz-Ares L.   +19 more
europepmc   +1 more source